Share This Author
Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model.
- Judith A. Smith, Lata Mathew, Maryam N. Burney, Pranavanand Nyshadham, R. Coleman
- Biology, MedicineGynecologic oncology
- 1 May 2016
Homogeneous and Functional Group Tolerant Ring-Closing Metathesis for DNA-Encoded Chemical Libraries
- Olivier B C Monty, Pranavanand Nyshadham, Nicholas Simmons
- Chemistry, BiologyACS combinatorial science
- 8 January 2020
TLDR
Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library
- Surendra Dawadi, Nicholas Simmons, M. Matzuk
- Biology, ChemistryProceedings of the National Academy of Sciences
- 8 July 2020
TLDR
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT
- Zhifeng Yu, A. Ku, M. Matzuk
- Biology, ChemistryProceedings of the National Academy of Sciences
- 26 February 2021
TLDR
Identifying OXA-48 Carbapenemase Inhibitors using DNA-Encoded Chemical Libraries.
- DorisMia Taylor, J. Anglin, T. Palzkill
- Biology, ChemistryACS infectious diseases
- 17 March 2020
TLDR
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors
- S. Chamakuri, Shuo Lu, D. Young
- Biology, ChemistryProceedings of the National Academy of Sciences
- 23 August 2021
TLDR
Identifying Oxacillinase-48 Carbapenemase InhibitorsUsing DNA-Encoded Chemical Libraries
- DorisMia Taylor, J. Anglin, T. Palzkill
- Biology, Chemistry
- 17 March 2020
TLDR
Design and construction of a stereochemically diverse piperazine-based DNA-encoded chemical library.
- S. Chamakuri, Mee-kyung Chung, D. Young
- Chemistry, BiologyBioorganic & medicinal chemistry
- 13 September 2021
Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363].
- Judith A. Smith, Lata Mathew, Maryam N. Burney, Pranavanand Nyshadham, R. Coleman
- MedicineGynecologic oncology
- 1 February 2017
...
...